Author

E. A. Hodge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:cryo-EM· 1 Research Focus:drug response / drug discovery· 1 Approach:microscopy & imaging analysis· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

K. K. Lee· 3 shared A. B. Ward· 1 shared A. C. Walls· 1 shared A. Palser· 1 shared A. Sahoo· 1 shared A. Schaefer· 1 shared A. Shiferaw· 1 shared B. Brown· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

K. K. Lee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cryo-ET of HIV reveals Env positioning on Gag lattice and structural variation among Env trimers

V. Mangala Prasad, D. P. Leaman, K. N. Lovendahl, J. T. Croft, M. A. Benhaim, E. A. Hodge, M. B. Zwick, K. K. Lee

This study uses cryo-ET to analyze HIV-1 Env structure and positioning in mature and immature virions, revealing structural variation and insights into Env incorporation and antigen presentation.

bioRxiv · Aug 31, 2021Biophysics

Changes at V2 apex of HIV-1 Clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies

A. Sahoo, E. A. Hodge, C. LaBranche, T. T. Styles, X. Shen, N. Cheedarla, A. Shiferaw, G. Ozorowski, W.-H. Lee, A. B. Ward, G. D. Tomaras, D. C. Montefiori, D. J. Irvine, K. K. Lee, R. R. Amara

bioRxiv · Jun 15, 2021 · PreprintImmunology

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

A. C. Walls, B. Fiala, A. Schaefer, S. Wrenn, M. N. Pham, M. Murphy, L. V. Tse, L. Shehata, M. A. O'Connor, C. Chen, M. J. Navarro, M. C. Miranda, D. Pettie, R. Ravichandran, J. C. Kraft, , N. P. King

This study designs SARS-CoV-2 nanoparticle vaccines that induce strong neutralizing antibodies in mice, with higher titers and lower doses than existing trimer vaccines.

bioRxiv · Aug 11, 2020Immunology